Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 28
Filtrar
1.
Sci Rep ; 13(1): 2541, 2023 02 13.
Artigo em Inglês | MEDLINE | ID: mdl-36781942

RESUMO

The West Florida Shelf (WFS), located in the eastern Gulf of Mexico, fosters high species richness and supports highly valuable fisheries. However, red tide events occur regularly that can impact fisheries resources as well as ecosystem state, functioning, and derived services. Therefore, it is important to evaluate and quantify the spatiotemporal impacts of red tides to improve population assessments, mitigate potential negative effects through management, and better understand disturbances to support an ecosystem-based management framework. To model red tide effects on the marine community, we used Ecospace, the spatiotemporal module of the ecosystem modeling framework Ecopath with Ecosim. The inclusion of both lethal and sublethal response functions to red tide and a comprehensive calibration procedure allowed to systematically evaluate red tide effects and increased the robustness of the model and management applicability. Our results suggest severe red tide impacts have occurred on the WFS at the ecosystem, community, and population levels in terms of biomass, catch, and productivity. Sublethal and indirect food-web effects of red tide triggered compensatory responses such as avoidance behavior and release from predation and/or competition.. This study represents a step forward to operationalize spatiotemporal ecosystem models for management purposes that may increase the ability of fisheries managers to respond more effectively and be more proactive to episodic mortality events, such as those caused by red tides.


Assuntos
Ecossistema , Proliferação Nociva de Algas , Florida , Biomassa , Cadeia Alimentar , Pesqueiros
3.
Ecol Evol ; 12(12): e9604, 2022 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-36523513

RESUMO

Understanding how species respond to the environment is essential in ecology, evolution, and conservation. Abiotic factors can influence species responses and the multi-dimensional space of abiotic factors that allows a species to grow represents the environmental niche. While niches are often assumed to be constant and robust, they are most likely changing over time and estimation can be influenced by population biology, sampling intensity, and computation methodology. Here, we used a 12-year time series of survey data to fit annual ecological niche models (ENMs) for 10 marine fish species by using two regression and two machine learning algorithms to evaluate the variation and differentiation of environmental niches. Fitted ENMs were used to develop multi-dimensional annual and pooled hypervolumes that were evaluated over time and across ENM algorithms, species, and years by computing volume, distance, and dissimilarity metrics for each annual estimated niche. We then investigated potential drivers of estimated hypervolume dynamics including species abundance, species occurrence, sampling effort, salinity, red tides severity, and algorithm. Overall, our results revealed that estimated niches varied over time and across ENM, species, and algorithms. Niche estimation was influenced over time by multiple factors suggesting high complexity on niche dynamics interpretation. Species with high occurrence tended to have a closer representation of the pooled niche and years with higher abundance tended to produce niche expansion. ENM algorithm, sampling effort, seawater salinity, and red tides explained the deviations from the pooled niche. Greater sampling effort led to more comprehensive and complete estimates of species niches. High red tides severity triggered niche contraction. Our results emphasize the predictable effects of population, sampling, and environment on species niche estimation and interpretation, and that each should be considered when performing and interpreting ecological niche analyses. Our niche analysis approach may contribute to effectively quantifying and assessing niche dynamics.

4.
Sci Rep ; 12(1): 19680, 2022 11 16.
Artigo em Inglês | MEDLINE | ID: mdl-36385268

RESUMO

Cumulative pressures are rapidly expanding in the Mediterranean Sea with consequences for marine biodiversity and marine resources, and the services they provide. Policy makers urge for a marine ecosystem assessment of the region in space and time. This study evaluates how the whole Mediterranean food web may have responded to historical changes in the climate, environment and fisheries, through the use of an ecosystem modelling over a long time span (decades) at high spatial resolution (8 × 8 km), to inform regional and sub-regional management. Results indicate coastal and shelf areas to be the sites with highest marine biodiversity and marine resources biomass, which decrease towards the south-eastern regions. High levels of total catches and discards are predicted to be concentrated in the Western sub-basin and the Adriatic Sea. Mean spatial-temporal changes of total and commercial biomass show increases in offshore waters of the region, while biodiversity indicators show marginal changes. Total catches and discards increase greatly in offshore waters of the Western and Eastern sub-basins. Spatial patterns and temporal mean changes of marine biodiversity, community biomasses and trophic indices, assessed in this study, aim at identifying areas and food web components that show signs of deterioration with the overall goal of assisting policy makers in designing and implementing spatial management actions for the region.


Assuntos
Biodiversidade , Ecossistema , Mar Mediterrâneo , Pesqueiros , Cadeia Alimentar
5.
Br J Clin Pharmacol ; 88(4): 1529-1550, 2022 02.
Artigo em Inglês | MEDLINE | ID: mdl-34622969

RESUMO

AIMS: Adalimumab is a biological therapy used to treat different chronic inflammatory diseases. At present, there is an increasing number of adalimumab biosimilars. To assume the acceptability of interchangeability between reference adalimumab and biosimilars, there should be evidence about efficacy and safety of this switching. Regulation of this practice falls under the authority of individual European Union Member States. The aim of this study is to systematically review the evidence on the efficacy, safety and immunogenicity of switching between reference adalimumab and biosimilars in different chronic immune-mediated inflammatory diseases. METHODS: Studies presenting data about switching between reference adalimumab and biosimilars were identified by sensitive search strategies in Medline and EMBASE from 1 January 2004 to 30 June 2021. RESULTS: A total of 471 references were obtained and 21 finally included in the analysis (total number of patients switching: 2802). Eight different adalimumab biosimilars were tested after receiving reference adalimumab. Eight articles included rheumatoid arthritis (RA), one miscellaneous rheumatic disease, six psoriasis (PSO) and six inflammatory bowel disease (IBD) patients. Overall, the efficacy results in the switching groups were comparable to those obtained in the arms of continuous biosimilar and continuous reference adalimumab. There were no significant differences in treatment emergent adverse events, anti-drug or neutralising antibodies among the three groups. CONCLUSIONS: Switching between reference adalimumab and biosimilars has no impact on efficacy, safety and immunogenicity in patients with RA, PSO and IBD. This finding was consistent for the different adalimumab biosimilars analysed. These conclusions could probably be extended to other rheumatic diseases such as psoriatic arthritis and ankylosing spondylitis.


Assuntos
Artrite Reumatoide , Medicamentos Biossimilares , Doenças Inflamatórias Intestinais , Psoríase , Doenças Reumáticas , Adalimumab/efeitos adversos , Artrite Reumatoide/tratamento farmacológico , Medicamentos Biossimilares/efeitos adversos , Doença Crônica , Humanos , Doenças Inflamatórias Intestinais/tratamento farmacológico , Psoríase/tratamento farmacológico , Doenças Reumáticas/tratamento farmacológico
6.
Mar Environ Res ; 164: 105227, 2021 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-33478732

RESUMO

There is a general lack of information related to the spatial structure and functioning of marine ecosystems considering seasonality. Here, we modeled the biomass distribution of eight commercial marine species in the northwestern Mediterranean Sea during winter and summer. We hypothesised that the seasonal differences of the water column and the spatial heterogeneity of oceanographic conditions in the study area could result in seasonal variations on the species biomass distributions. We employed a Bayesian hierarchical species distribution modelling approach (B-SDM) with data from two experimental trawl surveys to analyse which are the significant drivers in each season. Our results showed that bathymetry, temperature and fishing patterns are important variables explaining the species spatial biomass distributions. Furthermore, we found seasonal differentiation in the spatial distribution of biomass for all the studied species. Our results provide essential knowledge about the seasonal distributions of key species in the Mediterranean Sea, with important management implications.


Assuntos
Ecossistema , Teorema de Bayes , Biomassa , Mar Mediterrâneo , Estações do Ano
9.
Arch Esp Urol ; 73(6): 570-571, 2020 Jul.
Artigo em Inglês, Espanhol | MEDLINE | ID: mdl-32633255

RESUMO

53 year old renal transplanted male with secondary amyloidosis to Crohn´sdisease, sent to Dermatology given the presence of multiple red-purple or hyperkeratotic...


Varón de 53 años de edad, trasplantado renal hace 12 años por amiloidosis secundaria a enfermedad de Crohn, a tratamiento diario con 10 mg de prednisona....


Assuntos
Transplante de Rim , Sarcoma de Kaposi , Humanos , Masculino , Pessoa de Meia-Idade
10.
Eur J Dermatol ; 29(4): 383-386, 2019 Aug 01.
Artigo em Inglês | MEDLINE | ID: mdl-31475909

RESUMO

BACKGROUND: Actinic cheilitis (AC) is a chronic condition that affects mainly the lower lip. OBJECTIVES: To investigate the use of lip photoprotection in patients with AC. MATERIALS AND METHODS: A cross-sectional multicentre study of patients, ≥45 years of age, was performed in eight dermatology departments in the Galicia region over a period of one year. From 1,239 patients included in the study, 410 were diagnosed with AC and complete data were available for 408. An analysis of lip photoprotection habits and possible associations in patients with AC is reported. RESULTS: Mean age of patients with AC was 71.9 years and 53.8% were women. More than 90% of AC patients (370/408) had never used lip photoprotection. In the group of patients who used it, 62.16% of them had only used a single stick within the previous year. The only variable significantly associated with the use of lip sun protection was low Fitzpatrick's skin types I and II (p=0.039). Study limitations include the inclusion of patients 45 years or older and the use of a semiquantitative scale for measuring the frequency of application of lip photoprotection. CONCLUSION: To our knowledge, this is the first European study focused on lip photoprotection in patients suffering from AC. Only a minority of AC patients protect their lips from UV radiation. Specific lip sun protection recommendations should be promoted, especially in high-risk populations.


Assuntos
Queilite/prevenção & controle , Neoplasias Labiais/prevenção & controle , Lesões Pré-Cancerosas/patologia , Prevenção Primária/métodos , Protetores Solares/uso terapêutico , Raios Ultravioleta/efeitos adversos , Fatores Etários , Idoso , Queilite/epidemiologia , Queilite/patologia , Estudos Transversais , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Prevalência , Valores de Referência , Medição de Risco , Fatores Sexuais , Espanha
12.
Acta Derm Venereol ; 98(10): 970-974, 2018 Nov 05.
Artigo em Inglês | MEDLINE | ID: mdl-30085328

RESUMO

Actinic cheilitis is thought to be a premalignant lesion or a superficial squamous cell carcinoma. The prevalence of actinic cheilitis in Europe is unknown. The aim of this study was to determine the prevalence of actinic cheilitis in the Galicia region (north-west Spain). Secondary objectives were the description of risk factors of actinic cheilitis. A cross-sectional multicentre study in patients ≥ 45 years of age was performed in 8 dermatology departments in Galicia region during a 1-year period. The prevalence of actinic cheilitis was 31.3%. Significant and independent risk factors of actinic cheilitis after multivariate analysis were age ≥ 60 years, Fitzpatrick skin phototype II, outdoor working for more than 25 years, and previous history of non-melanoma skin cancer. This is the first cross-sectional multicentre study of the prevalence of actinic cheilitis in Europe. Actinic cheilitis was present in almost one-third of the screened patients. Lip examination should be performed in all patients with chronic actinic damage.


Assuntos
Carcinoma Basocelular/epidemiologia , Carcinoma de Células Escamosas/epidemiologia , Queilite/epidemiologia , Exposição Ocupacional , Neoplasias Cutâneas/epidemiologia , Fatores Etários , Idoso , Idoso de 80 Anos ou mais , Estudos Transversais , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Prevalência , Fatores de Risco , Pigmentação da Pele , Espanha/epidemiologia
14.
Acta Dermatovenerol Croat ; 26(1): 61-63, 2018 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-29782303

RESUMO

Clindamycin is a lincomycin-derived antibiotic useful for the treatment of anaerobic and Gram-positive aerobic bacterial infections. Cutaneous adverse reactions are usually maculopapular exanthemas, although hypersensitivity syndrome, acute generalized exanthematous pustulosis, and Stevens-Johnson syndrome have also been reported (1). We report the case of a patient with a maculopapular rash triggered by clindamycin who developed cutaneous lesions on striae distensae (SD). A 47-year-old woman was referred to our clinic for pruritic cutaneous lesions which had started 6 days earlier. Her past clinical history included hypertension, hypothyroidism, hyperuricemia, cholecystectomy, caesarean section, and endometriosis-related abdominal surgery, and she was taking levothyroxine, allopurinol, imidapril, and omeprazole. The skin rash first developed on her neck and back on the 3rd day of clindamycin oral treatment (300 mg every 6 hours), which was prescribed as antibiotic prophylaxis for a tooth implant. General malaise (but not fever) was also reported. Physical examination revealed an erythematous maculopapular eruption symmetrically distributed on the neck, abdomen, and back (Figure 1, A), with isolated lesions involving the proximal upper and lower limbs (Figure 1, B). There was a striking vertical distribution of skin lesions along the SD on the lateral sides of the abdomen (Figure 1, C). No mucosal involvement was found, and laboratory studies showed no abnormalities. Clindamycin withdrawal was followed by prescription of a course of oral deflazacort, starting at 30 mg daily and tapering down during a 9-day period. On the 5th day of treatment, the rash had almost cleared with minimal desquamation (Figure 1, D). Eight weeks after clearance of the skin rash, informed consent was obtained in order to perform an allergological evaluation of clindamycin, including prick and intradermal (ID) tests on the forearm and patch tests on the upper back (2). For patch testing, powder of the commercial capsules (Dalacin®) was diluted in petrolatum (pet.) and water (aq.), resulting in a final 1% clindamycin dilution. Parenteral clindamycin preparations were used in therapeutic concentrations for prick tests (150 mg/mL) and dilutions in saline of 1/100 and 1/10 for the ID test. Other authors have reported that these concentrations do not seem to irritate the skin (3-6). Prick and ID tests were assessed after 20 min and 24 hours, respectively. Patch tests were removed after the 2nd day, and late reactions were evaluated on day 2 and day 4. Prick and ID test results after 20 min were negative. Late results of ID tests with clindamycin (1.5 and 15 mg/mL) were positive: erythematous infiltrated papules about 7×7 mm and 18×15 mm were observed at 24 hours and lasted until the 8th day. Patch tests with clindamycin 1% in pet. and 1% in aq. were also positive (+ on day 2 and day 4). Positive late skin tests suggested delayed-type non-IgE-mediated allergic clindamycin hypersensitivity. Oral challenge tests are considered to be the gold standard to establish or exclude drug hypersensitivity. Due to the positive result of late skin test to clindamycin, oral challenge was not performed in our patient (3,5). The Koebner isomorphic phenomenon has been described in cutaneous reactions induced by drugs, such as antibiotics and chemotherapy. Chronic pressure on the skin is probably involved in the onset of skin lesions in hand-foot eruptions induced by tyrosine kinase inhibitors (sorafenib and sutinib). Solar exposure and cutaneous trauma also seem to play a role in the location of papulopustular eruptions caused by endothelial growth factor receptor inhibitors (erlotinib) (7). More frequent involvement in traumatized skin and surgical scars has been reported in the context of linear IgA bullous dermatosis and leukocytoclastic vasculitis triggered by vancomycin and cefuroxime (8). SD are produced by non-penetrating physical trauma, similar to friction or pressure. Different dermatoses can develop along SD skin lesions (like plaque psoriasis, pustular psoriasis, lichen planus, vitiligo, discoid lupus erythematosus, lupus vasculitis, urticarial vasculitis, or chronic graft-versus-host disease) (9). Bevacizumab, etretinate, and corticosteroid-induced ulcers, hyperpigmentation caused by bleomycin, and urticariform lesions triggered by diclofenac are examples of different type of drug-induced abnormalities involving SD (10). In summary, we identified clindamycin as the cause of the cutaneous reactions that occurred in our patient on the basis of the results of the skin tests and clinical history. Our findings confirmed a delayed-type hypersensitivity reaction, possibly involving a T-cell-mediated immunologic mechanism. Intradermal and patch tests were found to be useful in order to confirm the diagnosis (4,5). We did not find reports in the literature of drug-induced cutaneous eruptions along the SD as a manifestation of a Koebner phenomenon. Clinical underreporting of this phenomenon could explain the scarce literature on this cutaneous adverse reaction.


Assuntos
Clindamicina/efeitos adversos , Toxidermias/etiologia , Testes do Emplastro/métodos , Estrias de Distensão/etiologia , Administração Oral , Biópsia por Agulha , Clindamicina/uso terapêutico , Relação Dose-Resposta a Droga , Esquema de Medicação , Toxidermias/patologia , Feminino , Seguimentos , Humanos , Imuno-Histoquímica , Pessoa de Meia-Idade , Medição de Risco , Índice de Gravidade de Doença , Estrias de Distensão/patologia , Suspensão de Tratamento
15.
Acta Dermatovenerol Croat ; 25(4): 305-306, 2017 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-30064607

RESUMO

Dear Editor, Lupus panniculitis or lupus profundus is a rare inflammatory complication found in patients with systemic lupus erythematosus (SLE), or discoid lupus erythematosus (DLE) (1). When the breast is involved, the term lupus mastitis (LM) is used. This disease involving the breast is rare, and the lesions may precede, coincide with, or occur later than the onset of other lupus lesions. Tissue biopsy is required to confirm the suspected diagnoses of LM. We report a case of a patient with lupus mastitis due to the important differential diagnosis. A 60-year-old woman presented with a painful nodular lesion in her left breast that had appeared 15 days ago (Figure 1, a). She had been previously diagnosed with discoid lupus erythematosus 3 years ago. Physical examination revealed a deep and firm erythematous subcutaneous nodule without overlying skin involvement in the lower-central portion of the left breast. Laboratory findings were positive for antinuclear antibodies (1:80) and double-stranded deoxynucleic acid antibodies (1:10). Mammography and ultrasounds showed an area of increased density and irregular breast tissue along with an important thickening of the overlying skin (Figure 1, b). On suspicion of malignancy, a needle biopsy of the breast lesion was performed and showed vacuolar alteration and lymphocytic infiltrate in the basal layer. Subcutaneous fat showed a lobular panniculitis with a prominent lymphocytic infiltrate and hyalinization of the fat lobules (hyaline fat necrosis). Direct immunofluorescence of the face biopsy revealed IgA, IgG, IgM, and C3 granular deposition. Based on these results, a diagnosis of lupus mastitis associated with DLE was established. Antimalarial therapy resulted in complete resolution of the clinical features. Three years later, the patient presented with a disfiguring atrophy with retraction in the damaged areas of the breast (Figure 2). Lupus mastitis is a very unusual disease that most commonly affects middle-aged women. The first case of LM was described by Tuffanelli in 1971. The lesions usually present following the diagnosis of SLE/DLE; however, on rare occasions they may be observed earlier (2). The histophysiology of this disease remains unclear, but the predominant theory suggests an autoimmune-related etiology. Corroborating evidence for this theory includes the finding of immune complexes, both at the basement membrane of the dermal-epidermal junction and in the blood vessels in the areas of panniculitis (3). Lupus mastitis may be present in the breast as single or multiple subcutaneous nodules that may be tender or painful and can progress to chronic ulcers over time or resolve, leaving atrophic scars. The overlying skin can be normal, erythematous, poikilodermic or ulcerated. When skin changes are prominent, the lesion may clinically and radiologically mimic inflammatory breast carcinoma. Mammographic and ultrasounds findings include an ill-defined breast density with or without associated microcalcifications (4). Histologically, this disease is characterized by lobular lymphocytic panniculitis and predominantly involves the fat lobule and the presence of anucleated adipocytes in a background of a glassy-appearing collagenous stroma (hyaline fat necrosis). Fibrinoid necrosis of the vessel wall has also been reported, but is usually absent (5). Differential diagnosis of lupus mastitis includes inflammatory breast carcinoma, primary medullary carcinoma, and other immune-mediated inflammatory conditions such as diabetic mastopathy. The first line of treatment the use of antimalarial drugs such as hydroxychloroquine. Systemic steroids and cyclophosphamide have also been used. Surgical treatment should be considered only in patients who do not respond to management with medications. In summary, we reported a case of lupus mastitis in a patient with discoid lupus erythematosus. This dermatosis should be considered in the differential diagnosis of breast lesions in lupus patients, and a biopsy of the breast lesion is essential to reject suspected malignancy. If the disease is left untreated, unsightly atrophy will appear; it is thus important to diagnose early on. The course of the disease tends to be chronic with remission and flares, so patients should be followed-up regularly due to the risk of recurrences in the same area or in a different location.


Assuntos
Lúpus Eritematoso Discoide/complicações , Lúpus Eritematoso Discoide/diagnóstico , Mastite/etiologia , Mastite/patologia , Feminino , Humanos , Mastite/diagnóstico por imagem , Pessoa de Meia-Idade
19.
Dermatol Online J ; 20(9)2014 Sep 16.
Artigo em Espanhol | MEDLINE | ID: mdl-25244177

RESUMO

The onset of umbilical nodules with no previous abdominal surgeries or known endometriosis in other locations characterizes primary umbilical endometriosis. We present a 43-year-old woman with a painful umbilical nodule for several months. We report this case to emphasize the importance of the differential diagnosis of umbilical nodules, especially in women during the reproductive period.


Assuntos
Endometriose/patologia , Umbigo/patologia , Adulto , Diagnóstico Diferencial , Feminino , Humanos
20.
Am J Dermatopathol ; 36(6): e105-7, 2014 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-24887966

RESUMO

Viral-associated trichodysplasia spinulosa is an unusual condition with distinctive clinical and histopathological features. Initially described in patients immunosupressed as a result of solid organ transplantation, it has also been reported in patients treated with immunosuppressive drugs other than cyclosporine or being treated for hematological malignancies. Patients presented with disseminated follicular, hyperkeratotic papules, and variable degrees of alopecia. Histopathological examination revealed shaftless bulbous and dilated hair follicles with keratotic plugging of the infundibulum. The authors reported a case of viral-associated trichodysplasia in a 5-year-old boy treated for a lymphoblastic leukemia. Eruption persisted, although treated with emollients and keratolytics, but resolved spontaneously after completing the antineoplastic medication.


Assuntos
Protocolos de Quimioterapia Combinada Antineoplásica/efeitos adversos , Doenças do Cabelo/patologia , Doenças do Cabelo/virologia , Ictiose/patologia , Ictiose/virologia , Infecções por Polyomavirus/imunologia , Leucemia-Linfoma Linfoblástico de Células Precursoras/tratamento farmacológico , Pré-Escolar , Doenças do Cabelo/imunologia , Humanos , Ictiose/imunologia , Hospedeiro Imunocomprometido , Masculino , Mercaptopurina/administração & dosagem , Mercaptopurina/efeitos adversos , Metotrexato/administração & dosagem , Metotrexato/efeitos adversos , Infecções por Polyomavirus/complicações , Infecções por Polyomavirus/patologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...